Evidence map›Paper›PMID 1312715›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America1992

Thrombomodulin gene regulation by cAMP and retinoic acid in F9 embryonal carcinoma cells.

H Weiler-Guettler, K Yu, G Soff, L J Gudas, R D Rosenberg

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 1992. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 54 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Thrombomodulin and its role in inflammation.Seminars in immunopathology · 2012
    Review
  7. Loss of CAK phosphorylation of RAR{alpha} mediates transcriptional control of retinoid-induced cancer cell differentiation.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2010
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

H Weiler-GuettlerMassachusetts Institute of Technology, Cambridge 02139.
K Yu
G Soff
L J Gudas
R D Rosenberg
Massachusetts Institute of Technology · USCornell University · US

Funding

STUDY OF THE FIBRONECTIN FUNCTIONP01HL041484 · NHLBI · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI ROSENBERG, ROBERT D · 1988 to 2000
$2.7M
TRANSCRIPTIONAL REGULATION OF VWF GENEP01HL033014 · NHLBI · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI ROSENBERG, ROBERT D · 1985 to 1994
–
NHLBI NIH HHS HL33014NHLBI NIH HHS HL41484
6 · The paper itself

Abstract

Thrombomodulin (TM) expression was investigated during differentiation of F9 embryonal carcinoma cells into primitive or parietal endoderm. Exposure of F9 cells to retinoic acid (RA) triggers differentiation into primitive endoderm and induces the appearance of barely detectable amounts of TM mRNA, whereas treatment with dibutyryl cAMP plus theophylline (CT) augments the levels of TM mRNA to a 4-fold greater extent than RA. Exposure of F9 cells to RA plus CT initiates differentiation into parietal endoderm and synergistically increases the levels of TM mRNA by 10- to 12-fold compared with CT. The time-dependent establishment of cooperativity between RA and CT appears to be secondary to RA-induced differentiation to primitive endoderm. The above alterations in TM mRNA levels occur by a transcriptional mechanism as judged by nuclear run-on experiments. Transient gene expression experiments show that the human TM promoter is transactivated by coexpression of the human RA receptor beta. Thus, the mechanism of induction of TM expression in F9 cells undergoing differentiation to parietal endoderm appears to be similar, but not identical, to that noted for other late response genes.

Indexed as

AnimalsBase SequenceBucladesineCell LineCell NucleusCyclic AMPGene Expression Regulation, NeoplasticMiceMolecular Sequence DataOligodeoxyribonucleotidesPolymerase Chain ReactionReceptors, Cell SurfaceReceptors, ThrombinRNA, NeoplasmTeratomaTheophyllineBucladesineCyclic AMPOligodeoxyribonucleotidesReceptors, Cell SurfaceReceptors, ThrombinRNA, NeoplasmTheophyllineThrombinTretinoin

Identifiers

PMID1312715
PMCPMC48615
OpenAlexW1990134219

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.